Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Sep
3
2019
Statements of Efficacy and Safety Material Claim Limitations Foley & Lardner LLP
Jan
10
2020
Unpacking The Solicitor General’s Brief In Vanda Foley & Lardner LLP
Jun
27
2016
Will Supreme Court Clarify Sequenom's Patent-Eligibility? Foley & Lardner LLP
Apr
30
2020
USPTO Confirms Inventorship as Limited to Natural Human Beings Foley & Lardner LLP
Oct
6
2020
Federal Circuit Finds Recombinant Polypeptide Anticipated By Native Polypeptide Foley & Lardner LLP
Nov
2
2020
Skinny Label Doesn’t Prevent Infringement Liability Foley & Lardner LLP
Jan
6
2021
USPTO Proposes To Close Gap In Terminal Disclaimer Practice Foley & Lardner LLP
May
2
2017
How Will The Supreme Court Choreograph The Biosimilar Patent Dance? Foley & Lardner LLP
May
11
2017
Is Real IPR Institution Rate Higher When Petitioner Errors & Pre-Institution Settlements Are Considered? Foley & Lardner LLP
May
22
2017
Federal Circuit’s Primer on Equivalence Infringement of Chemical Process Patents Foley & Lardner LLP
May
31
2017
Supreme Court Holds First Authorized Domestic or International Sale Exhausts U.S. Patent Rights Foley & Lardner LLP
Jul
1
2021
What Will Arthrex Review Look Like? Foley & Lardner LLP
Jul
20
2021
Biden’s Executive Order on Competition Could Spell Changes for the Pharmaceutical Industry Foley & Lardner LLP
Mar
26
2015
Patent Term Adjustment In The Post-RCE Period -- Request for Continued Examination Foley & Lardner LLP
Sep
27
2021
Is it Unfair to Restrict Unfair Competition? The FTC May Soon Make Their Stance Known Foley & Lardner LLP
Mar
31
2015
No Collateral Challenge Of Patent Application Revival Foley & Lardner LLP
Apr
23
2015
Amicus Briefs On Biosimilar Patent Litigation Foley & Lardner LLP
Jan
5
2022
Can Automakers Use the Same Defenses to Software-Related Patent Infringement Suits? Foley & Lardner LLP
Jun
9
2015
Federal Circuit Finds Nunc Pro Tunc Agreement Does Not Confer Standing Foley & Lardner LLP
Oct
24
2017
Federal Circuit Finds NuvaRing Patent Nonobvious Without Hindsight Foley & Lardner LLP
Feb
21
2018
Re-Thinking Supply Chain Contracts in the World of Connected Things Foley & Lardner LLP
Sep
24
2015
U.S. Government Patent Infringement Precludes Induced Infringement Foley & Lardner LLP
Jul
24
2018
CAFC Finds Publication Did Not Inherently Disclose Aveed Composition Foley & Lardner LLP
Aug
14
2018
New USPTO Fees For 2021 Foley & Lardner LLP
Dec
8
2015
Proposed Rule Changes For IPR Appeals Foley & Lardner LLP
Dec
16
2015
Federal Circuit Provides Additional Insight into the Scope of Board Institution-Related Decisions That Are Not Appealable Foley & Lardner LLP
Jan
7
2016
Federal Circuit Backs PTAB Decision Curtailing A Party's Use Of "Supplemental" Information Foley & Lardner LLP
Jul
19
2023
IP Toolbox Is Crucial In AI-Powered Drug Discovery Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins